TIRZ (Tirzepatide) is a research-grade peptide that belongs to a class of compounds known as dual GIP and GLP-1 receptor agonists. It is widely discussed in scientific and clinical research for its role in metabolic pathways related to glucose regulation and energy balance.
TIRZ is primarily used in research settings to study mechanisms involved in insulin sensitivity, appetite signaling, and weight-related metabolic processes. Because of its dual-receptor activity, it has gained significant attention in metabolic and endocrinology research.




Reviews
There are no reviews yet.